Literature DB >> 26980921

Impact of Nodal Level Distribution on Survival in Oral Cavity Squamous Cell Carcinoma: A Population-Based Study.

Emily Marchiano1, Tapan D Patel1, Jean Anderson Eloy2, Soly Baredes3, Richard Chan Woo Park4.   

Abstract

OBJECTIVE: Regional lymph node metastasis is an important prognostic factor in squamous cell carcinoma of the head and neck, decreasing survival by up to 50%. Oral cavity squamous cell carcinoma (OC-SCCa) most commonly spreads to levels I, II, and III. STUDY
DESIGN: Retrospective analysis of a population-based tumor registry.
SETTING: Academic medical center. SUBJECTS AND METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was queried for cases of OC-SCCa from 2004 to 2011 (22,973 cases). Resulting data including patient demographics, clinicopathological features, topographical distribution of nodal metastasis, and survival based on lymph node level involvement were analyzed.
RESULTS: In total, 8281 patients were identified with OC-SCCa who underwent neck dissection. Level I, closely followed by levels II and III, represented the most commonly involved nodal basins. The 5-year disease-specific survival (DSS) for patients with only level I, II, or III was 42.0% compared with 30.6% for the level IV group (P < .0001) and 26.4% for the level V group (P < .0001). Surgery with adjuvant radiotherapy improved 5-year DSS for patients with level I to III, level IV, and level V neck disease compared with surgery alone (50.7% vs 48.6%, P = .0109; 39.9% vs 23.2%, P < .0001; and 33.3% vs 9.1%, P = .0005, for levels I-III, IV, and V, respectively).
CONCLUSION: Oral cavity squamous cell carcinoma most commonly involves nodal levels I, II, and III. Involvement of nodal level IV or V portends a worse prognosis than patients with only level I to III disease, and multimodality therapy should be considered for these patients. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2016.

Entities:  

Keywords:  SEER database; epidemiology; neck cancer; neck dissection; regional metastasis; sex; squamous cell carcinoma; survival

Mesh:

Year:  2016        PMID: 26980921     DOI: 10.1177/0194599816636356

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

1.  An oral cavity squamous cell carcinoma quantitative histomorphometric-based image classifier of nuclear morphology can risk stratify patients for disease-specific survival.

Authors:  Cheng Lu; James S Lewis; William D Dupont; W Dale Plummer; Andrew Janowczyk; Anant Madabhushi
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  Assessment of the Rate of Skip Metastasis to Neck Level IV in Patients With Clinically Node-Negative Neck Oral Cavity Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.

Authors:  Anton Warshavsky; Roni Rosen; Narin Nard-Carmel; Sara Abu-Ghanem; Yael Oestreicher-Kedem; Avraham Abergel; Dan M Fliss; Gilad Horowitz
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-06-01       Impact factor: 6.223

3.  Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.

Authors:  Jun Ju; Jia Wang; Chao Ma; Yun Li; Zhenyan Zhao; Tao Gao; Qianwei Ni; Moyi Sun
Journal:  Oncotarget       Date:  2016-08-09

Review 4.  Prevalence of Metastasis and Involvement of Level IV and V in Oral Squamous Cell Carcinoma: A Systematic Review.

Authors:  Ahmad A Altuwaijri; Turki M Aldrees; Mohammed A Alessa
Journal:  Cureus       Date:  2021-12-07

Review 5.  Adding Concomitant Chemotherapy to Postoperative Radiotherapy in Oral Cavity Carcinoma with Minor Risk Factors: Systematic Review of the Literature and Meta-Analysis.

Authors:  Alessia Di Rito; Francesco Fiorica; Roberta Carbonara; Francesca Di Pressa; Federica Bertolini; Francesco Mannavola; Frank Lohr; Angela Sardaro; Elisa D'Angelo
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.